3187 results for «899»
3187 results
ACS: how to approach special clinical scenarios
17 May 2024 – From EuroPCR 2024
This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...
PCI of bifurcation lesions: management of complications - Part 2
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the management of complications during PCI of bifurcation lesions. Cases cover topics such as navigating tricky ostial lesions, dealing with dissecting hematomas, undeflatable balloons, and distal left main perforations. Discussions focus on troubleshooting techniques and optimizing...
Thrombus management in a STEMI patient with high clot burden
17 May 2024 – From EuroPCR 2024
Discover the optimal timing for thrombus extraction and explore effective strategies for managing large thrombi. Learn about the latest tools and techniques, as well as the role of pharmacotherapy in supporting successful thrombus removal.
PCI of bifurcation lesions: management of complications - Part 3
17 May 2024 – From EuroPCR 2024
This session features additional selected EuroPCR 2024 clinical case submissions focusing on the management of complications during PCI of bifurcation lesions. Cases cover topics such as iatrogenic left main endarterectomy, left main dissections, and unexpected complications during various bifurcation stenting techniques. Discussions emphasize the importance of...
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
Imaging and physiology guided PCI
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...
Acute coronary syndromes: keep an eye open for unusual presentations
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions highlighting unusual presentations of acute coronary syndromes. Cases cover topics such as a "ring" completing the "crown", recurrent vasospastic angina culminating in STEMI, myocardial infarction of unusual cause, and primary PCI in dextrocardia. Discussions emphasize the importance...
Update on coronary physiology in 2024
17 May 2024 – From EuroPCR 2024
This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...
Personalised Vascular Care Award ceremony
16 May 2024 – From EuroPCR 2024
This session is the Personalised Vascular Care Award ceremony, sponsored by Abbott. The objectives and details of this session are not provided, as it is likely an event to recognize and celebrate achievements in the field of personalized vascular care.
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
Bicuspid disease - All you need to know
16 May 2024 – From EuroPCR 2024
This session is ideal if you want to understand the anatomical features of bicuspid aortic stenosis, learn about the latest post-TAVI clinical outcomes in bicuspid aortic valves, grasp key considerations for TAVI sizing in these cases, and analyze both self-expanding and balloon-expandable TAVI procedures in bicuspid...
TAVI with a new generation of valve and difficult arterial access - LIVE case
07 Dec 2023 – From GulfPCR-GIM 2023
An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...
How should I treat my female patients?
07 Dec 2023 – From GulfPCR-GIM 2023
This 100% all-female session, in every aspect, highlights the fact that female patients have a higher prevalence of SCAD and MINOCA, focuses on the advances in everyday technologies such as intracoronary imaging and intracoronary functional assessment that facilitate the establishment of a definitive diagnosis in many...
What does the interventionist need to know from the imager?
21 Nov 2023 – From PCR London Valves 2023
Take inspiration from the discussions on the case of a 78-year-old patient with HTN, HLD, and AF, presenting with symptomatic heart failure, or that of a 59-year-old female patient, former smoker, with HTN, DM, and persistent AF, who had been treated for breast carcinoma and post-chemotherapy...
Rapid-fire - Challenging structural interventions
21 Nov 2023 – From PCR London Valves 2023
Discover complex scenarios in structural interventions in this session: encounter an uncommon complication – ventricular septal defect – arising from transcatheter aortic valve replacement, delve into the decision-making process for a ventricular septal defect post-myocardial infarction in a young patient, navigate through the complexities of embolic...
Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...
Multivalvular disease: mitral and aortic valve challenges explored
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.
Challenges in TEER for secondary mitral regurgitation
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
